Depressive disorders are characterized by:

- Persistent low mood
- Loss of interest and enjoyment
- Neurovegetative disturbance
- Reduced energy

These symptoms lead to social and occupational dysfunction.

### Major Depressive Disorder
- Requires at least **five symptoms**.
- Classified as mild to severe.
- Severe episodes may include **psychotic symptoms** (e.g., paranoia, hallucinations).

### Aetiology
- Poorly understood; believed to arise from the interplay of biological, psychological, and social factors.

### Prevalence
- Very common, leading cause of disability.
- About **1 in 5** patients in primary care exhibit depressive symptoms.

### Diagnosis
- Conducted via psychiatric history and mental state exam.
- No definitive physical examination findings; typical observations include:
  - Depressed affect
  - Downcast gaze
  - Psychomotor slowing
  - Speech latency
  - Expressions of guilt or self-blame

### ICD-10 Diagnostic Criteria
**Core Symptoms** (at least 2 for 2+ weeks):
- Low mood
- Anhedonia
- Fatigue/low energy

**Associated Symptoms** (if core symptoms present):
- Disturbed sleep
- Poor concentration/indecisiveness
- Low self-confidence
- Change in appetite
- Suicidal thoughts or acts
- Psychomotor retardation/agitation
- Guilt or self-blame

**Severity Classification**:
- Mild: 4 symptoms
- Moderate: 5-6 symptoms
- Severe: >7 symptoms

**Further Classification**:
- Presence or absence of somatic and/or psychotic symptoms.

### Differential Diagnosis
Excludes:
- Medical disorders
- Sadness, burnout, adjustment disorder
- ADHD, bipolar disorder, borderline personality disorder
- Complicated grief, delirium, schizophrenia, schizoaffective disorder

### Investigations
- Initial tests: Thyroid function, metabolic panel, full blood count.
- Further tests: Serum vitamin B12, folate levels, 24-hour urinary cortisol.

### Screening Tools
- PHQ-2
- PHQ-9
- MDI (Major Depression Index)
- QIDS (Quick Inventory of Depressive Symptomatology)

### Management (Prescribing)
- **First-line**: Low-dose SSRIs (e.g., Fluoxetine, Citalopram, Sertraline).
  - Full effect in **up to 6 weeks**.
  - Continue effective dose for **6 months** after recovery.
- **Second-line**: Alternative SSRI.
- **Third-line**: Mirtazapine or Venlafaxine.

### Management (Non-Prescribing)
- **Mild Depression**: Low-intensity psychological interventions (e.g., sleep hygiene, mindfulness).
- **Moderate Depression**: High-intensity psychological intervention + antidepressants (e.g., CBT, interpersonal therapy).
- **Severe Depression**: Rapid specialist assessment, consider inpatient admission and electroconvulsive therapy.

### References
- UpToDate articles on unipolar depression and depression screening.
- NICE guidance on depression in adults.
- Oxford Handbook of Clinical Specialties, 10th Edition.